Published in
Taylor and Francis Group, Expert Opinion on Drug Safety, 9(17), p. 869-874, 2018
DOI: 10.1080/14740338.2018.1506763
Links
Tools
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System
Journal article published in 2018 by
Ippazio Cosimo Antonazzo,
Emanuel Raschi,
Emanuele Forcesi,
Trond Riise,
Kjetil Bjornevik 
,
Elisa Baldin,
Fabrizio De Ponti,
Elisabetta Poluzzi
,
Elisa Baldin,
Fabrizio De Ponti,
Elisabetta Poluzzi
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 